Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab

Lorenzo Dagna, Angelo Corti, Silvia Langheim, Barbara Guglielmi, Francesco De Cobelli, Claudio Doglioni, Gabriele Fragasso, Maria Grazia Sabbadini, Marina Ferrarini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number28
Publication statusPublished - Oct 1 2012

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this